Company profile: General Fluidics
1.1 - Company Overview
Company description
- Provider of the Axess Diagnostic Platform, an in vitro point-of-care testing solution that integrates hematology, clinical chemistry, and immunoassay tests for blood and urine, streamlining the testing process from sample collection to result delivery.
Products and services
- Axess Diagnostic Platform: A point-of-care platform that integrates hematology, clinical chemistry, and immunoassay tests, streamlining the entire process from sample collection to swift result delivery
- Blood Tests: The in vitro diagnostic tool delivers a growing array of blood tests, with workflow streamlined from sample collection to result delivery and categories spanning hematology, clinical chemistry, and immunoassay
- Urine Tests: The tool offers a growing array of urine tests at point-of-care, leveraging integrated clinical chemistry and immunoassay, with sample collection-to-result delivery streamlined via the Axess platform.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to General Fluidics
Hemagen Diagnostics
HQ: United States
Website
- Description: Provider of product distribution via partnerships with major IVD companies where synergies exist.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemagen Diagnostics company profile →
Faxitron
HQ: United States
Website
- Description: Provider of cabinet X-ray systems for specimen radiography, research, and NDT applications in medical, scientific, and industrial settings worldwide. Offers specimen radiography systems, digital and CCD-based units, compliant software, and the Faxitron Path Specimen Radiography System for detailed imaging and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faxitron company profile →
Immunostics
HQ: United States
Website
- Description: Provider of diagnostic solutions that assist in disease diagnosis, offering a compact automatic immunoassay analyzer, hemochroma PLUS hemoglobin/hematocrit device, hema-screen SPECIFIC GOLD colorectal cancer screening test, Swab-N-Go Home Test COVID-19 Ag with RAPIDCHECK app, Detector UA urine analysis strips, and Detector Strep A rapid test.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunostics company profile →
Advanced Instruments
HQ: United States
Website
- Description: Provider of scientific and analytical instruments and test kits for biopharmaceutical, clinical, food, dairy, and industrial microbiological markets, including freezing-point osmometers and the Solentim Cell Metric X for cell line development and assurance of clonality. Offers installation, qualification, training, validation, service agreements, and bioprocessing qualification services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Instruments company profile →
CTK Biotech
HQ: United States
Website
- Description: Provider of innovative immunodiagnostic tools and point-of-care diagnostic test kits for the IVD community worldwide, including SARS-CoV-2 rapid antigen, antibody, and real-time PCR tests; a self-administered COVID-19 home antigen test; an OnSite dengue IgG rapid test in the CDC two-step algorithm; and an HIV 1/2 antibody rapid test approved for commercialization in the EU.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTK Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for General Fluidics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to General Fluidics
2.2 - Growth funds investing in similar companies to General Fluidics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for General Fluidics
4.2 - Public trading comparable groups for General Fluidics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →